Aaron Bernstein, M.Phil., joined the Integrative Tumor Epidemiology Branch (ITEB) as a predoctoral fellow in 2019 and moved to the Trans-Divisional Research Program (TDRP) in 2020. Mr. Bernstein earned his master’s degree in epidemiology at University of Cambridge, United Kingdom, where, under the supervision of Dr. Paul Pharoah and Dr. Serena Nik-Zainal, he completed a bioinformatics thesis on the association between germline risk-conferring variants and somatic mutational signatures in breast cancer.
As a TDRP fellow, as well as an NIH Oxford-Cambridge Scholar and a Gates Cambridge Scholar, Mr. Bernstein is pursuing a Ph.D. at Cambridge. Under the mentorship of Montserrat García-Closas, M.D., Dr.P.H., Deputy Director and Director, TDRP, and Dr. Pharoah at Cambridge, Mr. Bernstein is performing research focused on the development of machine learning algorithms for the identification and prognostic evaluation of tumor-infiltrating lymphocytes in breast cancer histology slides. His ultimate goal is to become a physician-scientist with a specialty in oncology and research who focuses on the application of machine learning to cancer genomics and histology. Through a predoctoral fellowship, Mr. Bernstein is able to pursue collaborations with international leaders at the NCI, the University of Cambridge, and beyond, promoting the integration of his research directly into the clinic and helping to inform patient treatment globally.